GWAS for insulin resistance, however, are challenging to perform in large population cohorts as the protocols for directly measuring whole-body insulin sensitivity, such as the hyperinsulinemic-euglycemic clamp10, are difficult to perform at scale. The gene discussed is INS; the disease is Insulin resistance.